Company Name or Ticker Symbol
Search for other Categories

Opiant Pharmaceuticals, Inc.  (OPNT)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

Opiant Pharmaceuticals's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Jan 31 2017)
II. Quarter
(Oct 31 2016)
I. Quarter
(Jul 31 2016)
IV. Quarter
(Apr 30 2016)
III. Quarter
(Jan 31 2016)
II. Quarter
Y / Y Total Assets Change 878.67 % - - - -
Y / Y Net Income Change 168.25 % - - - -
Return On Assets (TTM) 125.86 % - 0 % 463.15 % 1195.41 %
Total Ranking # 20 # # # #
Seq. Total Assets Change 557.31 % 5.1 % -23.49 % 85.16 % -
Seq. Net Income Change -1873.11 % - - - -

Roa Comment
Opiant Pharmaceuticals, Inc. yielded Return on Asset in II. Quarter below company average, at 125.86 %.

ROA improved compare to previous quarter, due to net income growth.

Within Healthcare sector 4 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from to 20.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 3
Sector # 5
S&P 500 # 19

Return On Assets Statistics
High Average Low
125.86 %
125.86 %
125.86 %
(Jan 31 2017)  

You need to upgrade your Flash Player
Financial Statements
Opiant Pharmaceuticals's Equity $ 6 Millions OPNT's Balance sheet
Opiant Pharmaceuticals's Income $ 11 Millions Quarterly OPNT's Income Statement
OPNT's Income by Division See OPNT's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OPNT's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for OPNT's Competitors
Roa for Opiant Pharmaceuticals's Suppliers
Return On Asstes for OPNT's Customers

You may also want to know
OPNT's Roi OPNT's Inventory Turnover Ratio OPNT's Growth Rates OPNT's Dividend Comparisons
OPNT's Annual Roi OPNT's Profitability Ratios OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Roe OPNT's Valuation Ratios OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio

Companies with similar Return On Assets at Jan 31 2017, within Healthcare Sector ROA
Dariohealth Corp.  154.87 %
Ophthalix, Inc.  148.58 %
Elite Pharmaceuticals Inc  148.10 %
Capstone Therapeutics Corp.  146.85 %
Opiant Pharmaceuticals, Inc.  125.86 %
Mannkind Corp  115.31 %
Orgenesis Inc.  109.46 %
Tenax Therapeutics, Inc.  81.07 %
Nascent Biotech Inc.  75.71 %
Oculus Innovative Sciences, Inc.  56.90 %
Eagle Pharmaceuticals, Inc.  50.98 %
Five Prime Therapeutics Inc  50.79 %
Masimo Corp  44.81 %
Neurometrix, Inc.  42.40 %
Supernus Pharmaceuticals Inc  36.21 %
Biotelemetry, Inc.  32.92 %
Pro Dex Inc  32.53 %
United Therapeutics Corp  31.76 %
Enzo Biochem Inc  31.09 %
Baxter International Inc  30.71 %
Psychemedics Corp  27.58 %
Gilead Sciences Inc  26.30 %
Titan Pharmaceuticals Inc  25.84 %


Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
GFGY's Profile
Stock Price
GFGY's Financials
GFGY's Expectations
Business Description
Charts & Quotes
GFGY's News
GFGY's Competitors
Customers & Markets
Economic Indicators
GFGY's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com